CASP8-652 6N insertion/deletion polymorphism and overall cancer risk: evidence from 49 studies
Open Access
- 25 May 2017
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (34) , 56780-56790
Abstract
CASP8 -652 6N insertion/deletion polymorphism and overall cancer risk: evidence from 49 studies CASP8 -652 6N insertion/deletion polymorphism and overall cancer risk: evidence from 49 studiesKeywords
This publication has 70 references indexed in Scilit:
- Association of LEP G2548A and LEPR Q223R Polymorphisms with Cancer Susceptibility: Evidence from a Meta-AnalysisPLOS ONE, 2013
- Genetic Polymorphisms of the CASP8 Gene Promoter May Not Be Associated with Colorectal Cancer in Han Chinese from Southwest ChinaPLOS ONE, 2013
- CASP8 promoter polymorphism, mRNA expression and risk of prostate cancer among Chinese menJournal of Biomedical Research, 2011
- CASP8 polymorphisms contribute to cancer susceptibility: evidence from a meta-analysis of 23 publications with 55 individual studiesCarcinogenesis, 2010
- The Six-Nucleotide Deletion/Insertion Variant in the CASP8 Promoter Region Is Inversely Associated with Risk of Squamous Cell Carcinoma of the Head and NeckCancer Prevention Research, 2010
- Genetic variants and haplotypes of thecaspase-8andcaspase-10genes contribute to susceptibility to cutaneous melanomaHuman Mutation, 2008
- CASP8 variants D302H and −652 6N ins/del do not influence the risk of colorectal cancer in the United Kingdom populationBritish Journal of Cancer, 2008
- Association studies for finding cancer-susceptibility genetic variantsNature Reviews Cancer, 2004
- Cell DeathCell, 2004
- Apoptosis in the Pathogenesis and Treatment of DiseaseScience, 1995